100 related articles for article (PubMed ID: 31311100)
21. Hepatocyte growth factor promotes colonic epithelial regeneration via Akt signaling.
Kanayama M; Takahara T; Yata Y; Xue F; Shinno E; Nonome K; Kudo H; Kawai K; Kudo T; Tabuchi Y; Watanabe A; Sugiyama T
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G230-9. PubMed ID: 17412827
[TBL] [Abstract][Full Text] [Related]
22. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression.
Sheng G; Bernabe KQ; Guo J; Warner BW
Gastroenterology; 2006 Jul; 131(1):153-64. PubMed ID: 16831599
[TBL] [Abstract][Full Text] [Related]
24. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression.
Brand S; Beigel F; Olszak T; Zitzmann K; Eichhorst ST; Otte JM; Diebold J; Diepolder H; Adler B; Auernhammer CJ; Göke B; Dambacher J
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G960-8. PubMed ID: 16051921
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis.
Wang K; Kim MK; Di Caro G; Wong J; Shalapour S; Wan J; Zhang W; Zhong Z; Sanchez-Lopez E; Wu LW; Taniguchi K; Feng Y; Fearon E; Grivennikov SI; Karin M
Immunity; 2014 Dec; 41(6):1052-63. PubMed ID: 25526314
[TBL] [Abstract][Full Text] [Related]
26. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells.
Caruso R; Fina D; Peluso I; Stolfi C; Fantini MC; Gioia V; Caprioli F; Del Vecchio Blanco G; Paoluzi OA; Macdonald TT; Pallone F; Monteleone G
Gastroenterology; 2007 Jan; 132(1):166-75. PubMed ID: 17241869
[TBL] [Abstract][Full Text] [Related]
27. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
Xie YX; Liao R; Pan L; Du CY
Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
[TBL] [Abstract][Full Text] [Related]
28. Effects of transcription factor activator protein-1 on interleukin-8 expression and enteritis in response to Clostridium difficile toxin A.
Lee JY; Park HR; Oh YK; Kim YJ; Youn J; Han JS; Kim JM
J Mol Med (Berl); 2007 Dec; 85(12):1393-404. PubMed ID: 17639289
[TBL] [Abstract][Full Text] [Related]
29. IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling.
Hu WT; Li MQ; Liu W; Jin LP; Li DJ; Zhu XY
Mol Hum Reprod; 2014 Apr; 20(4):358-72. PubMed ID: 24344240
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation.
Clancy P; Koblar SA; Golledge J
Atherosclerosis; 2014 Sep; 236(1):108-15. PubMed ID: 25016365
[TBL] [Abstract][Full Text] [Related]
31. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
32. Glutamate accelerates RPE cell proliferation through ERK1/2 activation via distinct receptor-specific mechanisms.
García S; López E; López-Colomé AM
J Cell Biochem; 2008 May; 104(2):377-90. PubMed ID: 18022816
[TBL] [Abstract][Full Text] [Related]
33. IL22/IL-22R pathway induces cell survival in human glioblastoma cells.
Akil H; Abbaci A; Lalloué F; Bessette B; Costes LM; Domballe L; Charreau S; Guilloteau K; Karayan-Tapon L; Bernard FX; Morel F; Jauberteau MO; Lecron JC
PLoS One; 2015; 10(3):e0119872. PubMed ID: 25793261
[TBL] [Abstract][Full Text] [Related]
34. Esculetin inhibits cell proliferation through the Ras/ERK1/2 pathway in human colon cancer cells.
Park SS; Park SK; Lim JH; Choi YH; Kim WJ; Moon SK
Oncol Rep; 2011 Jan; 25(1):223-30. PubMed ID: 21109980
[TBL] [Abstract][Full Text] [Related]
35. Interleukin (IL)-31 activates signal transducer and activator of transcription (STAT)-1, STAT-5 and extracellular signal-regulated kinase 1/2 and down-regulates IL-12p40 production in activated human macrophages.
Kasraie S; Niebuhr M; Werfel T
Allergy; 2013 Jun; 68(6):739-47. PubMed ID: 23621408
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease.
Dambacher J; Beigel F; Seiderer J; Haller D; Göke B; Auernhammer CJ; Brand S
Gut; 2007 Sep; 56(9):1257-65. PubMed ID: 17449633
[TBL] [Abstract][Full Text] [Related]
37. IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2-ERK1/2 Pathway.
Yu XX; Hu Z; Shen X; Dong LY; Zhou WZ; Hu WH
Dig Dis Sci; 2015 May; 60(5):1265-72. PubMed ID: 25655003
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress induces extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase in cystic fibrosis lung epithelial cells: Potential mechanism for excessive IL-8 expression.
Boncoeur E; Criq VS; Bonvin E; Roque T; Henrion-Caude A; Gruenert DC; Clement A; Jacquot J; Tabary O
Int J Biochem Cell Biol; 2008; 40(3):432-46. PubMed ID: 17936667
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation.
Kim K; Kim G; Kim JY; Yun HJ; Lim SC; Choi HS
Carcinogenesis; 2014 Jun; 35(6):1352-61. PubMed ID: 24517997
[TBL] [Abstract][Full Text] [Related]
40. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
